Form 4: CEO Kroeger's Tax Withholding on MapLight Stock

MapLight Therapeutics CEO Christopher A. Kroeger reported a disposition of shares to cover tax obligations related to restricted stock unit awards.

Summary

• Christopher A. Kroeger, CEO and Director of MapLight Therapeutics, Inc., reported a change in beneficial ownership.
• On January 27, 2026, 204,146 shares of Voting Common Stock were withheld by MapLight Therapeutics, Inc. to satisfy tax withholding obligations.
• The shares were valued at $17.98 per share for tax purposes.
• Following this transaction, Kroeger directly owns 1,626,606 shares and indirectly owns 101,190 shares through the C&M Kroeger Nominee Trust.
• Kroeger's remaining shares are subject to a 180-day lock-up agreement from the initial public offering's final prospectus date of October 26, 2025.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine tax-related disposition of shares rather than a discretionary sale, indicating no change in management's underlying sentiment.

Positives

• The transaction is a non-discretionary tax withholding event, not a market sale by the CEO.
• Christopher A. Kroeger retains significant direct ownership of 1,626,606 shares and indirect ownership of 101,190 shares.

Negatives

• No direct negatives are indicated as this is a standard tax withholding transaction.

Risks

• The lock-up agreement on the remaining shares will expire 180 days after October 26, 2025, which could lead to increased selling pressure if insiders choose to sell shares once the lock-up period ends.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance beyond the mention of the lock-up agreement expiration.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. Tax-related dispositions of restricted stock units are common and generally not indicative of a change in management's confidence, unlike open market sales. This transaction is typical for executives receiving equity compensation.

Comparison to Industry Standards

• This is a standard Form 4 filing for a tax withholding event, which is a common practice in executive compensation across industries.

Related Party Transactions

• Christopher A. Kroeger indirectly owns 101,190 shares through the C&M Kroeger Nominee Trust, of which he is co-trustee with his spouse and has voting and dispositive power.

Stakeholder Impact

• Shareholders: The disposition of shares for tax purposes is a routine event and does not signal a change in the CEO's confidence. The upcoming expiration of the lock-up period could potentially increase the float and selling pressure, which is a factor for shareholders to monitor.

Next Steps

• The 180-day lock-up period for the reporting person's remaining shares will expire 180 days after October 26, 2025.

Key Dates

Recommendation

This Form 4 reports a non-discretionary tax withholding event, which is a routine part of executive compensation and does not reflect a change in the CEO's investment sentiment or the company's fundamentals. The CEO retains a substantial stake. Therefore, a "hold" recommendation is appropriate as this specific filing provides no new information to alter an existing investment thesis.

Keywords

MapLight Therapeutics, MPLT, Christopher A. Kroeger, Form 4, Insider Trading, Stock Ownership, CEO, Restricted Stock Units, Tax Withholding, Lock-up Agreement